A recent work from Prof. Vrati's Lab, published in the Journal of Virology, identifies AGPAT1 as a novel receptor for CHIKV on human cells and demonstrates that AGPAT1 has implications for understanding the virus pathogenesis and designing the receptor-blocking CHIKV antivirals.
The Regional Centre for Biotechnology (RCB) welcomed Dr. Shivkumar Kalyanaraman, CEO of the Anusandhan National Research Foundation (ANRF), for an in-depth visit, featuring interactions with researchers and a tour of key facilities including the BBB, ATPC, and IBDC.